Rang	Name	Position
1	Mr. Michael Rossi	CEO, President & Director
2	Mr. Thomas Gad	Founder, Chief Business Officer & Vice Chairman
3	Mr. Peter P. Pfreundschuh CPA	Executive VP, CFO & Treasurer
4	Mr. Joris Wiel Jan Wilms	Senior VP & COO
5	Dr. Torben Lund-Hansen M.Sc., Ph.D.	Senior VP & CTO
6	Ms. Courtney Dugan	VP & Head of Investor Relations
7	Mr. John W. LaRocca Esq.	Senior VP, General Counsel, Secretary & Chief Legal Officer
8	Dr. Norman D. LaFrance FACNP, FACP, M.D.	Chief Development Officer & Chief Medical Officer
9	Mr. Doug Gentilcore	Senior VP & Head of DANYELZA Business Unit
10	Ms. Natalie Tucker	Senior VP & Radiopharmaceutical Business Unit Head

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Paradigm Biocapital Advisors LP	9,32%	36,48 Mio. USD
2	BlackRock Inc	6,05%	23,66 Mio. USD
3	Caligan Partners LP	5,16%	20,17 Mio. USD
4	Sofinnova Ventures	4,83%	18,89 Mio. USD
5	Vanguard Group Inc	4,28%	16,73 Mio. USD
6	Polar Capital Holdings PLC	3,94%	15,41 Mio. USD
7	Geode Capital Management, LLC	1,87%	7,31 Mio. USD
8	State Street Corp	1,72%	6,72 Mio. USD
9	BOOTHBAY FUND MANAGEMENT, LLC	1,53%	5,97 Mio. USD
10	D. E. Shaw & Co LP	1,14%	4,45 Mio. USD
11	Dimensional Fund Advisors, Inc.	0,91%	3,55 Mio. USD
12	Nantahala Capital Management, LLC	0,77%	3,03 Mio. USD
13	Soleus Capital Management, L.P.	0,77%	3,01 Mio. USD
14	Northern Trust Corp	0,68%	2,65 Mio. USD
15	Morgan Stanley - Brokerage Accounts	0,64%	2,52 Mio. USD
16	Stonepine Capital Management Llc	0,63%	2,46 Mio. USD
17	Charles Schwab Investment Management Inc	0,61%	2,40 Mio. USD
18	Bank of America Corp	0,60%	2,36 Mio. USD
19	AQR Capital Management LLC	0,55%	2,17 Mio. USD
20	UBS Group AG	0,50%	1,97 Mio. USD